trial

Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia

NCTId NCT06361407
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 68 (estimated)
Sponsored by Centre Psychothérapique de Nancy
Primary completion 2027-10-28
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
68 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-06-28
Primary completion
2027-10-28
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Illusion task

Sponsors

Centre Psychothérapique de NancyLead Sponsor
Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator

Investigators

1
Anne GIERSCH, MD, PhDPrincipal Investigator

Sites

2 total
Marseille, FranceMontéléger, France

Facts & assertions

4 sourced
Enrollment
68
Phase
NA
Primary Completion Date
2027-10-28
Status
RECRUITING
relationships
The graph out of here
drug
Illusion task
drug
lead_sponsor
Centre Psychothérapique de Nancy
company
collaborator
Institut National de la Santé Et de la Recherche Médicale, France
company
indication
Schizophrenia
indication
Sensory Processing Disorder
indication
Schizophrenia
indication
investigator
Anne GIERSCH, MD, PhD
person